IL10 and colitis: Linking the components of this pathway together, the authors finally found that mice lacking both IL-10 and REL had reduced colonic inflammation and immune cell activation when compared with Il10-KO mice, suggesting that NF-κB activation is a key trigger for the dysregulated sphingolipid metabolism-mediated colitis that occurs in the absence of IL-10 signaling (Fig. 1).